Table 3.
Change in depression, anxious symptoms and obtaining treatment at follow-up, N=56. N differs from original group due to loss to follow-up and incomplete data, for example, not completing full scale.
| Outcome | Baseline | 6-week | Test parameter | Difference | P value | |
| PHQ-9a score, mean (SD) | 11.6 (5.1) | 10.2 (6.1) | Paired t test | t (df)=2.066 (55) | P=.04 | |
| SCARED-Cb score, score consistent with anxiety (≥3), n (%) | 48 (86) | 49 (88) | McNemar test | N=56 | P=.34 | |
| Treatment history (yes to having ever received), n (%) | ||||||
| Professional psychologist/counselor | 43 (66) | 45 (69) | McNemar test | N=57 | P=.34 | |
| Medication such as antidepressant | 32 (56) | 34 (52) | McNemar test | N=57 | P>.99 | |
aPHQ-9: Patient Health Questionnaire-9 modified for adolescents.
bSCARED-C: 5-item Screen for Child Anxiety Related Emotional Disorders.